-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $71

Benzinga·11/11/2026 21:09:04
UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $62 to $71.